|
B-Fcgr4 KO mice(CB-17 SCID)
|
111654 |
CB-17 SCID |
|
|
B-IL2rg KO rats
|
210513 |
Sprague Dawley |
Immune system (Immunodeficiency) |
|
B-Rag2 KO mice
|
110809 |
C57BL/6N |
l No mature T or B cellsl Used for efficacy
and toxicity verification |
|
B-Rag2 KO mice(C)
|
112883 |
BALB/cCrSlcNifdc |
|
|
B-Rag2 KO rats
|
210511 |
Sprague Dawley |
Immune system (Immunodeficiency) |
|
B-Rag2/F8 DKO mice
|
112250 |
C57BL/6 |
|
|
B-Rag2/Il2rg DKO mice
|
112937 |
C57BL/6N |
|
|
B-SDG rats
|
210512 |
Sprague Dawley |
Immune system (Immunodeficiency) |
|
B-hCD16A mice plus(CB-17 SCID)
|
113688 |
CB-17 SCID |
|
|
B-hCD16A/hNKP46 mice(CB-17 SCID)
|
112987 |
CB-17 SCID |
|
|
B-hCD98HC/Rag2 KO mice
|
112326 |
C57BL/6N |
Used for verification of efficacy and toxicity
of drugs targeting human CD98HC |
|
B-hNKP46 mice(CB-17 SCID)
|
112259 |
CB-17 SCID |
|
|
B-hTFR1, Rag2 KO mice
|
112904 |
C57BL/6 |
|
|
B-hTFR1, Rag2 KO mice
|
112904 |
C57BL/6 |
|
|
B-nude rats
|
112457 |
Sprague Dawley |
|
